Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Nefertiti A. El-Nikhely"'
Autor:
Moustafa A. Marey, Rania Abozahra, Nefertiti A. El-Nikhely, Miranda F. Kamal, Sarah M. Abdelhamid, Mohammed A. El-Kholy
Publikováno v:
Microbial Cell Factories, Vol 23, Iss 1, Pp 1-21 (2024)
Abstract Background The objectives of the current study were to extract pyocyanin from Pseudomonas aeruginosa clinical isolates, characterize its chemical nature, and assess its biological activity against different bacteria and cancer cells. Due to
Externí odkaz:
https://doaj.org/article/20541d6f1bb34053b470c50b141eacae
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 16, p 9086 (2024)
Cancer cells can escape death and surveillance by the host immune system in various ways. Programmed cell death ligand 1 (PD-L1) is a transmembrane protein that is expressed by most cell types, including cancer cells, and can provide an inhibitory si
Externí odkaz:
https://doaj.org/article/8ef7d2cd241b45db9bb71ba5abb59579
Autor:
Noor A. Abdullah, Hoda E. Mahmoud, Nefertiti A. El-Nikhely, Ahmed A. Hussein, Labiba K. El-Khordagui
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 11 (2023)
A carbon dots (CDs)-biolabeled heat-inactivated Lactiplantibacillus plantarum (HILP) hybrid was investigated as a multifunctional probiotic drug carrier with bioimaging properties using prodigiosin (PG) as anticancer agent. HILP, CDs and PG were prep
Externí odkaz:
https://doaj.org/article/dc09be574a10491fa218999ea84235c6
Autor:
Walaa M. Metwally, Salma E. El-Habashy, Nefertiti A. El-Nikhely, Hoda E. Mahmoud, Hoda M. Eltaher, Labiba El-Khordagui
Publikováno v:
International Journal of Pharmaceutics. 638:122920
Autor:
Wafaa M. Elsehly, Ghada M. Mourad, Radwa A. Mehanna, Marwa A. Kholief, Nefertiti A. El‐Nikhely, Ashraf K. Awaad, MennattAllah H. Attia
Publikováno v:
Journal of Biochemical and Molecular Toxicology. 36
Methyl paraben (MP) is an endocrine-disrupting compound that possesses estrogenic properties and contributes to an aberrant burden of estrogen signaling in the human breast and subsequently increasing the risks for the development of breast cancer. T